Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 54, Issue 79, 2007, Pages 2061-2068

  Chang, Chi Sen ^a,c   Huang, Shen Min ^b   Lin, Hui Hsuan ^c   Wu, Cheng Chung ^a,d   Wang, Chau Jong ^c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Hepatitis B virus; Hepatocellular carcinoma

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN CDC42; PROTEIN MCL 1;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CDC42 GTP-BINDING PROTEIN; FEMALE; HEPATITIS B; HUMANS; IMMUNOBLOTTING; LIVER NEOPLASMS; MALE; MIDDLE AGED; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 37749029969     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wu CC, Ho WL, Chen JT, Tang JS, Yeh DC, P'eng FK: Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma. Br J Surg 1999; 86:1391-1396.
2. Health and vital statistics: general health statistics 1998. Vol. 1. Taiwan, Republic of China: Department of Health, Executive Yuan, 1998; pp. 40-101.
3. Tang ZY: Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7:445-454.
4. Tung-Ping Poon R, Fan ST, Wong J: Risk factor, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232:10-24.
5. Bergsland EK: Molecular mechanisms underlying the development of hepatocellular carcinoma. Semin Oncol 2001; 28:521-531.
6. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-1462.
7. Hockenbery DM: The bcl-2 oncogene and apoptosis. Semin Immunol 1992; 4:413-420.
8. Adams JM, Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322-1326.
9. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN, Chisari FV: Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 1994; 91:12808-12812.
10. Waris G, Huh KW, Siddiqui A: Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 2001; 21:7721-7730.
11. Huang SN, Chisari FV: Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 1995; 21:620-626.
12. Wu CC, Hsieh SR, Chen JT, Ho WL, Lin MC, Yeh DC, Liu TJ, P'eng FK: An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. Arch Surg 2000; 135:1273-1279.
13. Wu CC, Hwang CR, Liu TJ, P'eng FK: Effects and limitations of prolonged intermittent ischemia for hepatic resection of the cirrhotic liver. Br J Surg 1996; 83:121-124.
14. International Union Against Cancer: Sobin L and Wittekind C (Eds.). TNM Classification of Malignant Tumors. 6th Edition. New York, USA: Wiley-Liss, 2002, pp. 65-68.
15. Ikeguchi M, Tatebe S, Kaibara N, Ito H: Changes in levels of expression of p53 and the product of the Bcl-2 in lines of gastric cancers during cisplatin-induced apoptosis. Eur Surg Res 1997; 29:397-402.
16. Chisari FV, Ferrari C, Mondelli MU: Hepatitis B virus structure and biology. Microb Pathog 1989; 6:311-325.
17. Chisari FV, Ferreri C: Hepatitis B virus immunopathogenesis. Annu Rev Immuno 1995; 13:29-60.
18. Chisari FV, Filippi P, Buras J, McLanchlan A, Popper H, Pinkert CA, Palmiter RD, Brinster RL: Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 1987; 84:6909-6913.
19. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Duncford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD: Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59:1145-1156.
20. Dunsford HA, Sell S, Chisari FV: Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res 1990; 50:3400-3407.
21. Pasquinelli C, Bhavani K, Chisari FV: Multiple oncogenesis and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res 1992; 52:2823-2829.
22. Thorgeirsson SS, Teramoto T, Factor VM: Deregulation of apoptosis in hepatocellular carcinoma. Semin Liver Dis 1998; 18:115-122.
23. Fritz G, Just I, Kaina B: Rho GTPases are overexpressed in human tumors. Int J Cancer 1999; 81:682-687.
24. Wang W, Yang LY, Yang ZL, Huang GW, Lu WQ: Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol 2003; 9:1950-1953.
25. Wang DS, Dou KF, Li KZ, Song ZS: Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway. World J Gastroenterol 2004; 10:299-302.
26. Fujikawa K, Shiraki K, Sugimoto K, Ito T, Yamanaka T, Takase K, Nakano T: Reduced expression of ICE/caspasel and CPP32/caspase3 in human hepatocellular carcinoma. Anticancer Res 2000; 20:1927-1932.
27. Osawa Y, Banno Y, Nagaki M, Brenner DA, Naiki T, Nozawa Y, Nakashima S, Moriwaki H: TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J Immunol 2001; 167:173-180.
28. Zhao M, Zhang NX, Economou M, Blaha I, Laissue JA, Zimmermann A: Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 1994; 25:237-245.
29. Guo XZ, Shao XD, Liu MP, Xu JH, Ren LN, Zhao JJ, Li HY, Wang D: Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. World J Gastroenterol 2002; 8:1059-1062.
30. Korsmeyer SJ, Gross A, Harada H, Zha J, Wang K, Yin XM, Wei M, Zinkel S: Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules. Cold Spring Harb Symp Quant Biol 1999; 64:343-350.
31. Oltvai ZN, Korsmeyer SJ: Checkpoints of dueling dimers foil death wishes. Cell 1994; 79:189-192.